Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,627 total articles
Polar Power's CEO Arthur Sams converted $614,700 of debt owed by the company into Series A Convertible Preferred shares, improving the company's balance sheet and shareholder equity. This move supports the company's efforts to regain compliance with Nasdaq listing requirements and signals confidence in future growth across multiple sectors includin…
HCW Biologics Inc., a clinical-stage biopharmaceutical company, announced the pricing of a $1.5 million private placement with an existing stockholder. The financing involves the issuance of pre-funded warrants and common stock purchase warrants subject to stockholder approval. Proceeds will support ongoing clinical trials of HCW9302 and advance st…
SeaStar Medical celebrated Dr. H. David Humes’ receipt of the University of Michigan's Distinguished University Innovator of the Year award for developing the Selective Cytopheretic Device (SCD) therapy. The therapy, commercialized as QUELIMMUNE, is FDA-approved for critically ill pediatric patients with acute kidney injury and sepsis, showing sign…
IMUNON, Inc. presented encouraging results from its Phase 2 OVATION 2 study of IMNN-001, demonstrating a 14.7-month median overall survival improvement in advanced ovarian cancer patients. The company highlighted the favorable safety profile of its IL-12 DNA plasmid immunotherapy and announced strong enrollment progress in the ongoing Phase 3 OVATI…
Terra Innovatum, a Nasdaq-listed company developing the SOLO™ Micro-Modular Reactor, applauds Italy's parliamentary approval of legislation restoring nuclear energy use, creating a new market for advanced nuclear technologies. The legislation supports sustainable nuclear power including small modular reactors, strengthening energy security and deca…
VisionWave Holdings, Inc. disclosed a purchase order valued at $20 million from Metal Machinery Components Trading FZCO for 200 STRATUM VARAN unmanned ground vehicles. The order's execution is contingent upon multiple conditions, including advance payment, financing proof, regulatory approvals, export licenses, and compliance reviews. Delivery is p…
Chaince Digital Holdings Inc., a Nasdaq-listed digital finance and technology company, completed a transaction repurchasing and permanently canceling all outstanding warrants issued in a private placement. The company paid $2 million in cash to warrant holders, eliminating potential dilution as no new shares were issued or reserved. This move simpl…
Cronos Group Inc., a global cannabis company, held its first Investor Day at its Kingsville location showcasing its commitment to research, development, and innovation through its diverse international cannabis brands. The event was webcast with presentations made available to investors.
Milestone Pharmaceuticals has enrolled the first patient in Canada for the ReVeRA-301 Phase 3 pivotal trial evaluating their FDA-approved etripamil nasal spray, CARDAMYST, for treatment of atrial fibrillation with rapid ventricular rate (AFib-RVR). This multinational trial aims to enroll 150 patients to assess the efficacy of self-administered etri…
Absci Corporation announced plans for a global, multi-center Phase 2 STORYLINE clinical trial to evaluate the efficacy and safety of ABS-201, an AI-designed anti-prolactin receptor antibody, for treating moderate to severe endometriosis-associated pain. The double-blind, placebo-controlled trial is planned to start in mid-2027, enrolling about 150 …
Getty Realty Corp., a net lease REIT specializing in convenience and automotive retail real estate, will release its third quarter 2026 financial results on October 21, 2026, followed by a conference call on October 22. The company owns a nationwide portfolio of 1,269 properties across 46 states and D.C.
Byrna Technologies Inc., a Nasdaq-listed company specializing in less-lethal personal security devices, announced it will release its fiscal Q3 2026 financial results on October 8, 2026, followed by a conference call to discuss the results.
Willis Towers Watson (NASDAQ: WTW) announced a strategic partnership with Softtek to address challenges faced by organizations in scaling AI workforce transformation. The collaboration combines WTW's expertise in workforce strategy and organizational change with Softtek's engineering and AI implementation capabilities, aiming to translate AI transf…
ABM Industries Incorporated (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, has won the 2026 Gartner Marketing and Communications Award for Brand and Reputation Excellence. The recognition honors ABM's successful enterprise-wide brand transformation campaign which significantly enhanced its market positioning…
Elicio Therapeutics announced that new pre-specified analyses from its Phase 2 AMPLIFY-7P study of ELI-002 7P, an immunotherapy targeting KRAS-driven pancreatic cancer, will be presented at ESMO Congress 2026. While the study did not meet its primary endpoint, the additional data provide valuable insights to refine the Phase 3 development strategy …
Lisata Therapeutics, through its subsidiary Marea Therapeutics, announced a late-breaking presentation of Phase 2b clinical data for MAR001, a novel monoclonal antibody targeting ANGPTL4 to treat elevated triglycerides, at the American Heart Association Scientific Sessions 2026. MAR001 aims to reduce triglycerides and improve cardiometabolic health…
Nuvectis Pharma announced that their drug candidate NXP200, an oral BRAF inhibitor targeting BRAF V600-mutant high-grade glioma, has been granted Breakthrough Therapy Designation by China's Center for Drug Evaluation. This designation highlights the promising clinical activity of NXP200 for patients with recurrent or progressive brain tumors. The c…
Tvardi Therapeutics announced new preclinical data showing that their oral STAT3 inhibitors, including next-generation TTI-109 and first-generation TTI-101, achieve high colon exposure, modulate multiple pathogenic pathways in ulcerative colitis (UC), and prevent colorectal cancer development in models. The data support advancing TTI-109 into clini…
ZenaTech's drone subsidiary ZenaDrone has entered the testing phase for its defense-focused quantum navigation system, designed to enable reliable drone operation in GPS-denied and satellite-compromised environments. The system aims to provide secure, redundantly layered navigation using quantum inertial sensing combined with AI path correction. In…
Annexon, Inc. announced presentations highlighting patient baseline characteristics and Phase 2 vision protection findings from the ARCHER program for their investigational neuroprotective drug vonaprument in Geographic Atrophy (GA). The ongoing Phase 3 ARCHER II trial aims to replicate Phase 2 positive vision outcomes, with primary endpoint result…
Dillard's, a leading US fashion retailer, has released the Southern Living Christmas Cookbook exclusively in its stores and online as part of its 32nd annual fundraiser for Ronald McDonald House. Profits from cookbook sales will benefit select Ronald McDonald House chapters across the US, continuing Dillard's long-standing commitment to charitable …
Diginex Limited, a Nasdaq-listed RegTech company specializing in ESG and sustainability solutions, has launched a new Group-wide Subject Matter Expertise (SME) initiative. This effort consolidates the company's scientific, regulatory, and methodological expertise across its product and advisory services to drive product innovation and deliver measu…
Quantum BioPharma's licensee, Unbuzzd Wellness Inc., has appointed Michael Zapolin as CEO with plans to finance and list the company on a stock exchange as well as execute a nationwide commercial marketing and product rollout in the U.S. Unbuzzd is a clinically validated beverage that accelerates alcohol metabolism, restores mental clarity, and red…
Trident Digital Tech Holdings Ltd announced that it has regained compliance with the Nasdaq minimum market value of listed securities requirement after its market value exceeded $35 million for 10 consecutive business days. This resolves the earlier deficiency notification received in March 2026, allowing the company to continue its listing on the …
SkyAI, Inc. acknowledges significant shareholder concerns reflected in the 2026 Annual Meeting voting results. The Board and management are committed to thoroughly engaging with shareholders and evaluating necessary actions related to capital allocation, corporate governance, strategic direction, and shareholder communications to reduce the company…
